ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Japan to produce 90m doses of AstraZeneca COVID-19 vaccine

Local drugmakers to make jabs soon as Tokyo becomes desperate to contain pandemic

AstraZeneca's vaccine will begin shipping in Japan as soon as May.   © Reuters

TOKYO -- Japan is gearing up to produce AstraZeneca COVID-19 shots as it grows desperate to secure enough vaccine for its population of 126 million amid global supply constraints, Nikkei has learned.

Production will be undertaken by JCR Pharmaceuticals, a biotechnology company that does not have experience producing vaccines but can culture the necessary adenoviral vectors.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more